Author

Nazha Hamdani

Ruhr University BochumORCID 0000-0002-3053-0008Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:ChIP-seq· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Adel ElsherbinyiD· 1 shared Alessandro MengozziiD· 1 shared Ali R. Saadatmand· 1 shared Almut SchulzeiD· 1 shared Christian U. OeingiD· 1 shared Coenraad WithaariD· 1 shared Era GoricaiD· 1 shared Eric SchogeriD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Adel ElsherbinyORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular BiologybioRxivPreprintJan 14, 2026

Selective class IIa HDAC inhibition reverses diastolic dysfunction in cardiometabolic HFpEF

Jiale Huang, Friederike C. Schreiter, Junyu Fan…·Johannes Backs

This study shows that selective class IIa HDAC inhibition improves diastolic dysfunction in HFpEF without adverse effects.

2 citations

mouseexperimental assay

𝕏 PostBluesky

PhysiologyCirculation ResearchPeer-reviewedApr 11, 2025

Chromatin Remodeling by the Histone Methyltransferase SETD2 Drives Lipotoxic Injury in Cardiometabolic Heart Failure with Preserved Ejection Fraction

Sarah Costantino, S. A. Mohammed, Samuele Ambrosini…·Francesco Paneni

This study shows that SETD2 promotes lipotoxic injury in cHFpEF by regulating SREBP1 and lipid metabolism, and its inhibition improves cardiac function.

20 citationstop 1%

𝕏 PostBluesky